These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 38427145)
1. Pre-hepatectomy dynamic circulating tumor DNA to predict pathologic response to preoperative chemotherapy and post-hepatectomy recurrence in patients with colorectal liver metastases. Liu M; Bao Q; Zhao T; Huang L; Zhang D; Wang Y; Yan X; Wang H; Jin K; Liu W; Wang K; Xing B Hepatol Int; 2024 Jun; 18(3):1029-1039. PubMed ID: 38427145 [TBL] [Abstract][Full Text] [Related]
2. Dynamic monitoring of circulating tumor DNA to predict prognosis and efficacy of adjuvant chemotherapy after resection of colorectal liver metastases. Wang DS; Yang H; Liu XY; Chen ZG; Wang Y; Fong WP; Hu MT; Zheng YC; Zheng Y; Li BK; Yuan YF; Chen G; Pan ZZ; Song L; Li YH; Xu RH Theranostics; 2021; 11(14):7018-7028. PubMed ID: 34093868 [No Abstract] [Full Text] [Related]
3. Circulating tumor DNA dynamics and recurrence risk in patients undergoing curative intent resection of colorectal cancer liver metastases: A prospective cohort study. Tie J; Wang Y; Cohen J; Li L; Hong W; Christie M; Wong HL; Kosmider S; Wong R; Thomson B; Choi J; Fox A; Field K; Burge M; Shannon J; Kotasek D; Tebbutt NC; Karapetis C; Underhill C; Haydon A; Schaeffer J; Ptak J; Tomasetti C; Papadopoulos N; Kinzler KW; Vogelstein B; Gibbs P PLoS Med; 2021 May; 18(5):e1003620. PubMed ID: 33939694 [TBL] [Abstract][Full Text] [Related]
4. Postoperative circulating tumour DNA is associated with pathologic response and recurrence-free survival after resection of colorectal cancer liver metastases. Bolhuis K; van 't Erve I; Mijnals C; Delis-Van Diemen PM; Huiskens J; Komurcu A; Lopez-Yurda M; van den Broek D; Swijnenburg RJ; Meijer GA; Punt CJA; Fijneman RJA EBioMedicine; 2021 Aug; 70():103498. PubMed ID: 34333237 [TBL] [Abstract][Full Text] [Related]
5. Personalized circulating tumor DNA monitoring improves recurrence surveillance and management after curative resection of colorectal liver metastases: a prospective cohort study. Li Y; Xu J; Hu X; Chen Y; Liu F; Chen Y; Ma X; Dong Q; Sun L; Mo S; Zhang L; He X; Tong S; Wu H; Li W; Cai S; Zhu S; Pan Q; Peng J Int J Surg; 2024 May; 110(5):2776-2787. PubMed ID: 38445460 [TBL] [Abstract][Full Text] [Related]
6. Impact of Preoperative Circulating Tumor DNA Status on Survival Outcomes After Hepatectomy for Resectable Colorectal Liver Metastases. Kobayashi S; Nakamura Y; Taniguchi H; Odegaard JI; Nomura S; Kojima M; Sugimoto M; Konishi M; Gotohda N; Takahashi S; Yoshino T Ann Surg Oncol; 2021 Aug; 28(8):4744-4755. PubMed ID: 33393041 [TBL] [Abstract][Full Text] [Related]
7. Recurrence Prediction by Circulating Tumor DNA in the Patient with Colorectal Liver Metastases After Hepatectomy: A Prospective Biomarker Study. Liu W; Jin KM; Zhang MH; Bao Q; Liu M; Xu D; Wang K; Xing BC Ann Surg Oncol; 2023 Aug; 30(8):4916-4926. PubMed ID: 37219651 [TBL] [Abstract][Full Text] [Related]
8. Prospective Study of Perioperative Circulating Tumor DNA Dynamics in Patients Undergoing Hepatectomy for Colorectal Liver Metastases. Newhook TE; Overman MJ; Chun YS; Dasari A; Tzeng CD; Cao HST; Raymond V; Parseghian C; Johnson B; Nishioka Y; Kawaguchi Y; Uppal A; Vreeland TJ; Jaimovich A; Arvide EM; Cristo JV; Wei SH; Raghav KP; Morris VK; Lee JE; Kopetz S; Vauthey JN Ann Surg; 2023 May; 277(5):813-820. PubMed ID: 35797554 [TBL] [Abstract][Full Text] [Related]
9. Pathologic response after preoperative therapy predicts prognosis of Chinese colorectal cancer patients with liver metastases. Wang Y; Yuan YF; Lin HC; Li BK; Wang FH; Wang ZQ; Ding PR; Chen G; Wu XJ; Lu ZH; Pan ZZ; Wan DS; Sun P; Yan SM; Xu RH; Li YH Chin J Cancer; 2017 Oct; 36(1):78. PubMed ID: 28969708 [TBL] [Abstract][Full Text] [Related]
11. Effect of Co-mutation of RAS and TP53 on Postoperative ctDNA Detection and Early Recurrence after Hepatectomy for Colorectal Liver Metastases. Nishioka Y; Chun YS; Overman MJ; Cao HST; Tzeng CD; Mason MC; Kopetz SW; Bauer TW; Vauthey JN; Newhook TE; J Am Coll Surg; 2022 Apr; 234(4):474-483. PubMed ID: 35290266 [TBL] [Abstract][Full Text] [Related]
12. Codon 13 KRAS mutation predicts patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases. Margonis GA; Kim Y; Sasaki K; Samaha M; Amini N; Pawlik TM Cancer; 2016 Sep; 122(17):2698-707. PubMed ID: 27244540 [TBL] [Abstract][Full Text] [Related]
13. Tumor Mutational Burden From Circulating Tumor DNA Predicts Recurrence of Hepatocellular Carcinoma After Resection: An Emerging Biomarker for Surveillance. Wehrle CJ; Hong H; Kamath S; Schlegel A; Fujiki M; Hashimoto K; Kwon DCH; Miller C; Walsh RM; Aucejo F Ann Surg; 2024 Sep; 280(3):504-513. PubMed ID: 38860385 [TBL] [Abstract][Full Text] [Related]
14. Post-chemotherapeutic CEA and CA19-9 are prognostic factors in patients with colorectal liver metastases treated with hepatic resection after oxaliplatin-based chemotherapy. Sakamoto Y; Miyamoto Y; Beppu T; Nitta H; Imai K; Hayashi H; Baba Y; Yoshida N; Chikamoto A; Baba H Anticancer Res; 2015 Apr; 35(4):2359-68. PubMed ID: 25862901 [TBL] [Abstract][Full Text] [Related]
15. Utility of Circulating Tumor DNA Assessment in Characterizing Recurrence Sites after Optimal Resection for Metastatic Colorectal Cancer. Bansal VV; Belmont E; Godley F; Dhiman A; Witmer HD; Li S; Liao A; Eng OS; Turaga KK; Shergill A J Am Coll Surg; 2024 Jun; 238(6):1013-1020. PubMed ID: 38299640 [TBL] [Abstract][Full Text] [Related]
16. [Long-term outcomes of patients undergoing hepatectomy for bilateral multiple colorectal liver metastases-a propensity score matching analysis]. Bao Q; Wang K; Wang HW; Jin KM; Xing BC Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):976-983. PubMed ID: 33053993 [No Abstract] [Full Text] [Related]
17. Significance of postoperative follow-up of patients with metastatic colorectal cancer using circulating tumor DNA. Benešová L; Hálková T; Ptáčková R; Semyakina A; Menclová K; Pudil J; Ryska M; Levý M; Šimša J; Pazdírek F; Hoch J; Blaha M; Minárik M World J Gastroenterol; 2019 Dec; 25(48):6939-6948. PubMed ID: 31908397 [TBL] [Abstract][Full Text] [Related]
18. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Adam R; Delvart V; Pascal G; Valeanu A; Castaing D; Azoulay D; Giacchetti S; Paule B; Kunstlinger F; Ghémard O; Levi F; Bismuth H Ann Surg; 2004 Oct; 240(4):644-57; discussion 657-8. PubMed ID: 15383792 [TBL] [Abstract][Full Text] [Related]
19. Parenchymal-sparing hepatectomy for colorectal liver metastases reduces postoperative morbidity while maintaining equivalent oncologic outcomes compared to non-parenchymal-sparing resection. Andreou A; Gloor S; Inglin J; Di Pietro Martinelli C; Banz V; Lachenmayer A; Kim-Fuchs C; Candinas D; Beldi G Surg Oncol; 2021 Sep; 38():101631. PubMed ID: 34298267 [TBL] [Abstract][Full Text] [Related]
20. RAS Mutation is Associated with Unsalvageable Recurrence Following Hepatectomy for Colorectal Cancer Liver Metastases. Okuno M; Goumard C; Kopetz S; Vega EA; Joechle K; Mizuno T; Omichi K; Tzeng CD; Chun YS; Vauthey JN; Conrad C Ann Surg Oncol; 2018 Aug; 25(8):2457-2466. PubMed ID: 29786130 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]